3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > AIDS/HIV -

HIV screening not just for the young

AIDS/HIVJun 17, 08

Screening for HIV infection in people older than 55 years of age is likely to be worthwhile in terms of the cost of screening balanced against the potential savings in heath care costs and the gain in years of life, according to a report in the Annals of Internal Medicine.

Recent guidelines by the U.S Centers for Disease Control and Prevention recommend screening for HIV infection in everyone between 13 and 64 years of age. Whether screening is cost-effective for people in the 55-to-75 age range, however, was unclear.

The cost and benefits of screening depend on the total expense of testing and counseling, the amount of disease in the community and how likely any given person is to be infected, and the potential benefits when the disease is caught early.

Dr. Gillian D. Sanders, from Duke University in Durham, North Carolina, and colleagues calculate that streamlined counseling and HIV screening of 65-year-old people would cost less than $60,000 for every quality-adjusted life-year saved, even in areas where only 1 in 1000 people are infected.

That cost-benefit ratio compares favorably with other interventions considered worthwhile, the team points out.

“Advanced age alone should not preclude screening for HIV. Rather, for many people in this age group, the cost-effectiveness of screening is within the range of that of other accepted interventions,” the investigators conclude.

SOURCE: Annals of Internal Medicine, June 17, 2008.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Hepatitis C more prevalent than HIV/AIDS or Ebola yet lacks equal attention
  Cell-associated HIV mucosal transmission: The neglected pathway
  Offering option of initial HIV care at home increases use of ART
  HIV-1 movement across genital tract cells surprisingly enhanced by usurping antibody response
  Indonesia probes Bali tattoo HIV infection report
  Obama raises U.S. goal on fighting AIDS
  New device to test blood can spot cancer cells, HIV on the fly
  Rare HIV-positive individuals shed light on how body could effectively handle infection
  New research examines how HIV infections occur on the molecular level
  An answer to a longstanding question: How HIV infection kills T cells
  Researchers say uncover HIV, insulin resistance link
  Beatrice Hahn and George Shaw, Pioneers in HIV Research, to Join Penn Medicine

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site